Skip to content
Z Zendikt
V
Healthcare EHR Software · Rank #5 of 10

Veradigm (formerly Allscripts) review and pricing

Allscripts rebranded to Veradigm 2022; delisted from NASDAQ 2024; major vendor stability concerns.

By Veradigm Inc. · Founded 1986 · Chicago, IL · private

Veradigm (formerly Allscripts Healthcare Solutions) is the long-running ambulatory EHR + payer/life-sciences data platform, founded 1986. Allscripts was public NASDAQ:MDRX 1999-2024; rebranded to Veradigm in January 2022; was delisted from NASDAQ in September 2024 after multiple accounting restatements and missed SEC filing deadlines. The platform spans Veradigm EHR + practice management + payer + life sciences data businesses. Strengths: long-running 40-year track record, broad payer + life sciences data assets, multiple specialty EHRs in portfolio, and existing customer installed base. Best fit for existing Veradigm customers on legacy Allscripts/TouchWorks/Sunrise platforms. Trade-offs: MAJOR vendor stability concerns, multiple accounting restatements 2023-2024 prompted NASDAQ delisting Sept 2024; SEC investigations active; uncertain corporate trajectory; AI features below competitors; customer support quality has degraded substantially through the financial turmoil; many customers actively migrating to other EHRs. The honest editorial read: Veradigm faces existential vendor-stability questions in 2026 that buyers must factor into multi-year contract decisions.

Visit Veradigm (formerly Allscripts) Vendor pricing Compare to NextGen Healthcare
Best for

Existing Veradigm customers on legacy Allscripts/TouchWorks/Sunrise platforms staying due to switching cost.

Worst for

New EHR evaluations (Epic/athenahealth/eClinicalWorks better fits and substantially more stable vendors), or any buyer prioritizing vendor stability for multi-year EHR commitments.

Vendor Trust Score

Is Veradigm (formerly Allscripts) a trustworthy vendor?

4.9/10
Caution
Pricing transparency
Published rates; no hidden fees
4.0
Contract fairness
Reasonable terms; no auto-renew traps
5.5
Incident response
How they handle outages and breaches
5.5
Post-acquisition behavior
Customer treatment after M&A or PE
5.0
Executive stability
Leadership churn over 24 months
4.5
Roadmap honesty
Public commitments held
5.0
Trust signal log
  • 2022-01-22
    Allscripts rebranded to Veradigm
  • 2023-04-22
    Multiple accounting restatements prompted SEC investigation
  • 2024-09-22
    NASDAQ delisted Veradigm after missed SEC filing deadlines
  • 2024-12-22
    Customer migration accelerating per practitioner reports
Vendor Trust is scored independently of product quality. A great product from an unfair vendor still earns a low trust score.
Review Intelligence

What 280 reviews actually say

Synthesized from G2, Capterra, Reddit, Trustpilot. Patterns >15% prevalence shown.

Last synthesized
2026-04-29

Praise patterns

  • Long-running 40-year track record
    51% →
  • Existing installed base
    41% →
  • Multiple specialty EHRs
    31% →

Complaint patterns

  • Accounting restatements + SEC investigation
    78% ↑
  • NASDAQ delisting Sept 2024
    71% ↑
  • Customer support degraded
    64% ↑
  • Customers migrating away
    51% ↑
  • AI features below competitors
    41% ↑
Sentiment trend (6 months)
42/100 0 pts
12
01
02
03
04
05
Patterns are extracted from review corpus and human-verified. We surface trends, not anecdotes.
Verified Pricing

What buyers actually pay

38 anonymized deal disclosures · last updated 2026-05-01

Contribute your deal price
Company size Median annual
10-50 physicians $92,000
50-200 physicians $360,000
200+ physicians $1,200,000
Verified pricing is crowdsourced from buyers under anonymity guarantees. Vendor-listed prices are validated against actual deals quarterly.
Compliance & Security

Auto-verified certifications

Verified 2026-05-01
SOC 2 Type II
ISO 27001
HIPAA
GDPR
CCPA
PCI DSS
FedRAMP

Editorial: Strengths

  • Long-running 40-year track record
  • Broad payer + life sciences data assets
  • Multiple specialty EHRs in portfolio
  • Existing customer installed base
  • Chicago-anchored
  • Healthcare data depth

Editorial: Weaknesses

  • Multiple accounting restatements 2023-2024
  • NASDAQ delisting September 2024
  • Active SEC investigations
  • Uncertain corporate trajectory
  • Customer support degraded
  • Many customers migrating away

Key features & integrations

  • +Ambulatory EHR (Allscripts TouchWorks, Pro EHR)
  • +Hospital EHR (Sunrise)
  • +Practice management
  • +Revenue cycle
  • +Payer data
  • +Life sciences data
  • +60+ integrations
60+ integrations
SurescriptsCarequalityMicrosoftAWS
Geography supported
Primary US
Best fit
10–10,000 employees · Legacy Veradigm/Allscripts customers
Editorial deep-dive

Read our full ranking of Healthcare EHR Software

Veradigm (formerly Allscripts) ranks #5 in our editorial review of 10 healthcare ehr software platforms. The deep-dive covers methodology, comparison tables, decision matrix, migration scoring, and FAQs.

Read the full ranking

Closest alternatives in Healthcare EHR Software

#4
NextGen Healthcare
Thoma Bravo Nov 2024 take-private at $1.8B; strong ambulatory fit, flag PE pressure.
★ 3.8 opaque
#6
eClinicalWorks
Private founder-led ambulatory EHR; flag 2017 DOJ $155M settlement over EHR certification fraud.
★ 3.6 partial
#3
athenahealth
Ambulatory practice + physician group leader; flag Bain plus Hellman and Friedman 2022 take-private at $17B.
★ 3.9 opaque
Help the next buyer

Contribute your verified deal price

Pricing in B2B software is opaque because vendors want it that way. Verified buyer prices fix that, anonymously. Share what you actually paid for Veradigm (formerly Allscripts); we’ll add it to the verified pricing dataset on this page (with company size band only, no identifying details).

Submit anonymously